Probable Interaction Between Lycium barbarum (Goji) and Warfarin

被引:44
作者
Rivera, Claudio A. [2 ]
Ferro, Carol L. [3 ]
Bursua, Adam J. [4 ]
Gerber, Ben S. [1 ]
机构
[1] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60608 USA
[2] Univ So Calif, Dept Med, Los Angeles, CA USA
[3] Univ So Calif, Dept Psychiat, Los Angeles, CA USA
[4] Univ Illinois, Dept Pharm Practice, Coll Pharm, Chicago, IL USA
来源
PHARMACOTHERAPY | 2012年 / 32卷 / 03期
关键词
goji juice; goji berry; Lycium barbarum; warfarin; COMPLEMENTARY; THERAPIES;
D O I
10.1002/j.1875-9114.2012.01018.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lycium barbarum (also called goji berry), a Chinese herb used as a supplement for health benefits, is traditionally consumed by the Chinese in the form of a tea. Goji juice, a widely available beverage in the United States, also contains this herb. We describe a 71-year-old Ecuadorean-American woman who was taking warfarin and was hospitalized for a markedly elevated, indeterminate international normalized ratio (INR) (prothrombin time > 120 sec) after consumption of goji juice. She had undergone knee surgery approximately 3 months earlier at which time warfarin therapy was started. She reported no changes in dietary habits or lifestyle other than drinking goji juice for 4 days before hospitalization. On presentation to the emergency department, she described symptoms of epistaxis, bruising, and rectal bleeding. After discontinuation of the goji juice and warfarin, the patient was treated with phytonadione, and her INR decreased to 2.6 over 2 days. Application of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 6) between the patient's elevated INR with associated bleeding and her concomitant use of L. barbarum and warfarin. Two other published reports have described similar interactions between warfarin and a tea containing L. barbarum. Patients should be educated about avoiding popular herbal drinks, such as goji juice, that contain L. barbarum while they are taking warfarin. In addition, clinicians should question patients about their use of herbal therapies and document such use in their medical records before prescribing drugs such as warfarin.
引用
收藏
页码:E50 / E53
页数:4
相关论文
共 14 条
  • [1] A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji)
    Amagase, Harunobu
    Farnsworth, Norman R.
    [J]. FOOD RESEARCH INTERNATIONAL, 2011, 44 (07) : 1702 - 1717
  • [2] [Anonymous], 2008, Complementary and Alternative Medicine Use among Adults and Children: United States, 2007
  • [3] Burke D. S., 2005, Current Topics in Nutraceutical Research, V3, P259
  • [4] Women's reasons for complementary and alternative medicine use: Racial/ethnic differences
    Chao, Maria T.
    Wade, Christine
    Kronenberg, Fredi
    Kalmuss, Debra
    Cushman, Linda F.
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (08) : 719 - 722
  • [5] Eck PO, 2009, FASEB J, V23
  • [6] Potential interactions between alternative therapies and warfarin
    Heck, AM
    DeWitt, BA
    Lukes, AL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (13) : 1221 - 1227
  • [7] Variation in complementary and alternative medicine (CAM) use across racial/ethnic groups and the development of ethnic-specific measures of CAM use
    Hsiao, AF
    Wong, MD
    Goldstein, MS
    Yu, HJ
    Andersen, RM
    Brown, ER
    Becerra, LM
    Wenger, NS
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (03) : 281 - 290
  • [8] Herb-drug interactions - A literature review
    Hu, ZP
    Yang, XX
    Ho, PCL
    Chan, SY
    Heng, PWS
    Chan, E
    Duan, W
    Koh, HL
    Zhou, SF
    [J]. DRUGS, 2005, 65 (09) : 1239 - 1282
  • [9] Long-term trends in the use of complementary and alternative medical therapies in the United States
    Kessler, RC
    Davis, RB
    Foster, DF
    Van Rompay, MI
    Walters, EE
    Wilkey, SA
    Kaptchuk, TJ
    Eisenberg, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (04) : 262 - 268
  • [10] Lam AY, 2002, CJOM, V13, P10